nach oben

Erschienen in:

01.04.2015 | Other Forms of Diabetes (R Bonadonna, Section Editor)

Diabetes After Pancreatic Surgery: Novel Issues

verfasst von: Marina Scavini, Erica Dugnani, Valentina Pasquale, Daniela Liberati, Francesca Aleotti, Gaetano Di Terlizzi, Giovanna Petrella, Gianpaolo Balzano, Lorenzo Piemonti

Erschienen in: Current Diabetes Reports | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

In the developed world, pancreatic surgery is becoming more common, with an increasing number of patients developing diabetes because of either partial or total pancreatectomy, with a significant impact on quality of life and survival. Although these patients are expected to consume increasing health care resources in the near future, many aspects of diabetes after pancreatectomy are still not well defined. The treatment of diabetes in these patients takes advantage of the therapies used in type 1 and 2 diabetes; however, no specific guidelines for its management, both immediately after pancreatic surgery or in the long term, have been developed. In this article, on the basis of both the literature and our clinical experience, we address the open issues and discuss the most appropriate therapeutic options for patients with diabetes after pancreatectomy.

Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR. History of the pancreas. Am J Surg. 1983;146:539–50.PubMed

Bassi C, Malleo G. The unsolved mystery of Johann Georg Wirsung and of (his?) pancreatic duct. Surgery. 2011;149:153–5.PubMed

Jolles S. Paul Langerhans. J Clin Pathol. 2002;55:243.PubMedCentralPubMed

Are C, Dhir M, Ravipati L. History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers. HPB (Oxford). 2011;13:377–84.

Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of vater. Ann Surg. 1935;102:763–79.PubMedCentralPubMed

Luft R. Oskar Minkowski: discovery of the pancreatic origin of diabetes, 1889. Diabetologia. 1989;32:399–401.PubMed

The Nobel Lecture on Diabetes and Insulin. Can Med Assoc J. 1926; 16:301.

Roe BA. Frederick Sanger (1918–2013). Genome Res. 2014;24:xi–xii.PubMedCentralPubMed

Priestley JT, Comfort MW, Sprague RG. Total pancreatectomy for hyperinsulinism due to islet-cell adenoma; follow-up report 5 1/2 years after operation, including matabolic studies. Ann Surg. 1949;130:211–7.PubMedCentralPubMed

10.

Lahat G, Ben Haim M, Nachmany I, et al. Pancreatic incidentalomas: high rate of potentially malignant tumors. J Am Coll Surg. 2009;209:313–9.PubMed

11.

Lemmens VE, Bosscha K, van der Schelling G, et al. Improving outcome for patients with pancreatic cancer through centralization. Br J Surg. 2011;98:1455–62.PubMed

12.

Balzano G, Zerbi A, Capretti G, et al. Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy. Br J Surg. 2008;95:357–62.PubMed

13.

Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142:761–8.PubMed

14.

Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142:20–5.PubMed

15.•

Harnoss JC, Ulrich AB, Harnoss JM, et al. Use and results of consensus definitions in pancreatic surgery: a systematic review. Surgery. 2014;155:47–57. A good review about the definition of complication after pancreatic surgery.PubMed

16.

Bliss LA, Yang CJ, Chau Z et al. Patient selection and the volume effect in pancreatic surgery: unequal benefits? HPB (Oxford). 2014.

17.

Donahue TR, Reber HA. Pancreatic surgery. Curr Opin Gastroenterol. 2013;29:552–8.PubMed

18.

Schmidt CM, Turrini O, Parikh P, et al. Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg. 2010;145:634–40.PubMed

19.

Gooiker GA, Lemmens VE, Besselink MG, et al. Impact of centralization of pancreatic cancer surgery on resection rates and survival. Br J Surg. 2014;101:1000–5.PubMed

20.

Yoshioka R, Yasunaga H, Hasegawa K, et al. Impact of hospital volume on hospital mortality, length of stay and total costs after pancreaticoduodenectomy. Br J Surg. 2014;101:523–9.PubMed

21.•

Mohammed S, Van Buren IG, Fisher WE. Pancreatic cancer: advances in treatment. World J Gastroenterol. 2014;20:9354–60. A good review about the advances in treatment of pancreatic cancer.PubMedCentralPubMed

22.

Hackert T, Buchler MW. Pancreatic cancer: advances in treatment, results and limitations. Dig Dis. 2013;31:51–6.PubMed

23.

van der Gaag NA, Berkhemer OA, Sprangers MA, et al. Quality of life and functional outcome after resection of pancreatic cystic neoplasm. Pancreas. 2014;43:755–61.PubMed

24.

Park JW, Jang JY, Kim EJ, et al. Effects of pancreatectomy on nutritional state, pancreatic function and quality of life. Br J Surg. 2013;100:1064–70.PubMed

25.

Velanovich V. The association of quality-of-life measures with malignancy and survival in patients with pancreatic pathology. Pancreas. 2011;40:1063–9.PubMed

26.

Pezzilli R, Falconi M, Zerbi A, et al. Clinical and patient-reported outcomes after pancreatoduodenectomy for different diseases: a follow-up study. Pancreas. 2011;40:938–45.PubMed

27.

Halloran CM, Cox TF, Chauhan S, et al. Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study. Pancreatology. 2011;11:535–45.PubMed

28.•

Balzano G, Piemonti L. Autologous islet transplantation in patients requiring pancreatectomy for neoplasm. Curr Diab Rep. 2014;14:512. A good review about islet autotransplantation after pancreatectomy for pancreatic neoplasm.PubMed

29.•

Balzano G, Dugnani E, Pasquale V et al. Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients. Acta Diabetol. 2014. A prospective observational study about diabetes after pancreatic surgery.

30.

Alberti K. Diabetes secondary to pancreatopathy: an example of brittle diabetes. In: Diabetes Secondary to Pancreatopathy. International Congress Series 762. A. Tiengo KGMMA, DelPrato S, Vranic M (Eds) Amsterdam: Excerpta Medica; 1988. pp. 7–20.

31.

Billings BJ, Christein JD, Harmsen WS, et al. Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg. 2005;9:1059–66. discussion 1066–7.PubMed

32.

Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol. 2004;18:947–55.PubMed

33.

Jethwa P, Sodergren M, Lala A, et al. Diabetic control after total pancreatectomy. Dig Liver Dis. 2006;38:415–9.PubMed

34.

Hutchins RR, Hart RS, Pacifico M, et al. Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients. Ann Surg. 2002;236:612–8.PubMedCentralPubMed

35.

Hutchins RR, Kojodjojo P, Ho R, et al. Short and long-term outcome of pancreatic surgery in a district general hospital. J R Coll Surg Edinb. 2002;47:548–51.PubMed

36.

Muller MW, Friess H, Kleeff J, et al. Is there still a role for total pancreatectomy? Ann Surg. 2007;246:966–74. discussion 974–5.PubMed

37.

Stauffer JA, Nguyen JH, Heckman MG, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford). 2009;11:483–92.

38.

Reddy S, Wolfgang CL, Cameron JL, et al. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg. 2009;250:282–7.PubMed

39.

Sakata N, Egawa S, Motoi F, et al. Institutional indications for islet transplantation after total pancreatectomy. J Hepatobiliary Pancreat Surg. 2008;15:488–92.PubMed

40.

Gaia E, Salacone P. Medical complications of pancreatic resections. JOP. 2007;8:114–7.PubMed

41.

Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014; 37(Suppl 1):S81-90.

42.

Andersen DK, Andren-Sandberg A, Duell EJ, et al. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas. 2013;42:1227–37.PubMed

43.

Roberts KJ, Blanco G, Webber J et al. How severe is diabetes after total pancreatectomy? A case-matched analysis. HPB (Oxford). 2013.

44.•

Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology. 2011;11:279–94. A good review about pancreatogenic diabetes.PubMed

45.•

Maeda H, Hanazaki K. Pancreatogenic diabetes after pancreatic resection. Pancreatology. 2011;11:268–76. A good review about diabetes after pancreatic resection.PubMed

46.

Cui Y, Andersen DK. Diabetes and pancreatic cancer. Endocr Relat Cancer. 2012;19:F9–F26.PubMed

47.

Del Prato S, Riva F, Devide A, et al. Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis. Acta Diabetol Lat. 1980;17:111–8.PubMed

48.

Del Prato S, Tiengo A, Baccaglini U, et al. Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. Diabetologia. 1983;25:252–9.PubMed

49.

Polonsky KS, Herold KC, Gilden JL, et al. Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes. Diabetes. 1984;33:1112–9.PubMed

50.

Del Prato S, Vigili de Kreutzenberg S, Trevisan R, et al. Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. Diabetologia. 1985;28:277–81.PubMed

51.

Vigili de Kreutzenberg S, Maifreni L, Lisato G, et al. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion. J Clin Endocrinol Metab. 1990;70:1023–9.PubMed

52.

Lee BW, Kang HW, Heo JS, et al. Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy. Metabolism. 2006;55:135–41.PubMed

53.

Chen N, Unnikrishnan IR, Anjana RM, et al. The complex exocrine-endocrine relationship and secondary diabetes in exocrine pancreatic disorders. J Clin Gastroenterol. 2011;45:850–61.PubMed

54.

Slezak LA, Andersen DK. Pancreatic resection: effects on glucose metabolism. World J Surg. 2001;25:452–60.PubMed

55.

Nosadini R, del Prato S, Tiengo A, et al. Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes. 1982;31:346–55.PubMed

56.

Gall FP, Muhe E, Gebhardt C. Results of partial and total pancreaticoduodenectomy in 117 patients with chronic pancreatitis. World J Surg. 1981;5:269–75.PubMed

57.

Muggeo M, Moghetti P, Faronato PP, et al. Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects. J Endocrinol Invest. 1987;10:311–9.PubMed

58.

Seymour NE, Volpert AR, Lee EL, et al. Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide. Am J Surg. 1995;169:105–9. discussion 110.PubMed

59.

Inoue K, Tobe T, Suzuki T, et al. Plasma cholecystokinin and pancreatic polypeptide response after radical pancreatoduodenectomy with Billroth I and Billroth II type of reconstruction. Ann Surg. 1987;206:148–54.PubMedCentralPubMed

60.

Sive A, Vinik AI, Van Tonder S, Lund A. Impaired pancreatic polypeptide secretion in chronic pancreatitis. J Clin Endocrinol Metab. 1978;47:556–9.PubMed

61.

Adrian TE, McKiernan J, Johnstone DI, et al. Hormonal abnormalities of the pancreas and gut in cystic fibrosis. Gastroenterology. 1980;79:460–5.PubMed

62.

Andersen DK, Ruiz CL, Burant CF. Insulin regulation of hepatic glucose transporter protein is impaired in chronic pancreatitis. Ann Surg. 1994;219:679–86. discussion 686–7.PubMedCentralPubMed

63.

Seymour NE, Spector SA, Andersen DK, et al. Overexpression of hepatic pancreatic polypeptide receptors in chronic pancreatitis. J Surg Res. 1998;76:47–52.PubMed

64.

Bajorunas DR, Fortner JG, Jaspan J, Sherwin RS. Total pancreatectomy increases the metabolic response to glucagon in humans. J Clin Endocrinol Metab. 1986;63:439–46.PubMed

65.

Schrader H, Menge BA, Breuer TG, et al. Impaired glucose-induced glucagon suppression after partial pancreatectomy. J Clin Endocrinol Metab. 2009;94:2857–63.PubMed

66.

Donowitz M, Hendler R, Spiro HM, et al. Glucagon secretion in acute and chronic pancreatitis. Ann Intern Med. 1975;83:778–81.PubMed

67.

Linehan IP, Lambert MA, Brown DC, et al. Total pancreatectomy for chronic pancreatitis. Gut. 1988;29:358–65.PubMedCentralPubMed

68.

Ewald N, Bretzel RG, Fantus IG, et al. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab Res Rev. 2007;23:386–91.PubMed

69.

Muscogiuri G, Mezza T, Prioletta A, et al. Removal of duodenum elicits GLP-1 secretion. Diabetes Care. 2013;36:1641–6.PubMedCentralPubMed

70.

Korner J, Bessler M, Inabnet W, et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007;3:597–601.PubMedCentralPubMed

71.

Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res. 2004;36:747–54.PubMed

72.

Knop FK, Vilsboll T, Larsen S, et al. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. Am J Physiol Endocrinol Metab. 2007;292:E324–30.PubMed

73.

Ewald N, Bretzel RG. Diabetes mellitus secondary to pancreatic diseases (Type 3c)—are we neglecting an important disease? Eur J Intern Med. 2013;24:203–6.PubMed

74.

Ewald N, Kaufmann C, Raspe A, et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28:338–42.PubMed

75.

Ito T, Otsuki M, Igarashi H, et al. Epidemiological study of pancreatic diabetes in Japan in 2005: a nationwide study. Pancreas. 2010;39:829–35.PubMed

76.

Hardt PD, Brendel MD, Kloer HU, Bretzel RG. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care. 2008;31 Suppl 2:S165–9.PubMed

77.

Murphy MM, Knaus 2nd WJ, Ng SC, et al. Total pancreatectomy: a national study. HPB (Oxford). 2009;11:476–82.

78.••

De Bruijn KM, van Eijck CH. New-onset diabetes after distal pancreatectomy: a systematic review. Ann Surg. 2014.A meta-analysis about diabetes incidence after partial pancreatectomy.

79.

Sauvanet A. Functional results of pancreatic surgery. Rev Prat. 2002;52:1572–5.PubMed

80.

Duron F, Duron JJ. [Pancreatectomy and diabetes]. Ann Chir. 1999;53:406–11.PubMed

81.

Dresler CM, Fortner JG, McDermott K, Bajorunas DR. Metabolic consequences of (regional) total pancreatectomy. Ann Surg. 1991;214:131–40.PubMedCentralPubMed

82.

Kiviluoto T, Schroder T, Karonen SL, et al. Glycemic control and serum lipoproteins after total pancreatectomy. Ann Clin Res. 1985;17:110–5.PubMed

83.

Piorkowski RJ, Blievernicht SW, Lawrence Jr W, et al. Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period. Am J Surg. 1982;143:189–93.PubMed

84.

Forssmann K, Schirr K, Schmid M, et al. [Postoperative follow-up in patients with partial Whipple duodenopancreatectomy for chronic pancreatitis]. Z Gastroenterol. 1997;35:1071–80.PubMed

85.

Heise JW, Katoh M, Luthen R, Roher HD. Long-term results following different extent of resection in chronic pancreatitis. Hepatogastroenterology. 2001;48:864–8.PubMed

86.

Warren KW, Poulantzas JK, Kune GA. Life after total pancreatectomy for chronic pancreatitis: clinical study of eight cases. Ann Surg. 1966;164:830–4.PubMedCentralPubMed

87.

Sato T, Noto N, Matsuno S, Miyakawa K. Follow-up results of surgical treatment for chronic pancreatitis. Present status in Japan. Am J Surg. 1981;142:317–23.PubMed

88.

Bittner R, Butters M, Buchler M, et al. Glucose homeostasis and endocrine pancreatic function in patients with chronic pancreatitis before and after surgical therapy. Pancreas. 1994;9:47–53.PubMed

89.

Boyle PJ, Kempers SF, O’Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:1726–31.PubMed

90.

Dammann HG, Besterman HS, Bloom SR, Schreiber HW. Gut-hormone profile in totally pancreatectomised patients. Gut. 1981;22:103–7.PubMedCentralPubMed

91.

Buchler MW, Friess H, Muller MW, et al. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg. 1995;169:65–9. discussion 69–70.PubMed

92.

Epelboym I, Winner M, DiNorcia J, et al. Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection. J Surg Res. 2014;187:189–96.PubMed

93.

Dorlon M, Owczarski S, Wang H, et al. Increase in postoperative insulin requirements does not lead to decreased quality of life after total pancreatectomy with islet cell autotransplantation for chronic pancreatitis. Am Surg. 2013;79:676–80.PubMed

94.

Roberts KJ, Blanco G, Webber J, et al. How severe is diabetes after total pancreatectomy? A case-matched analysis. HPB (Oxford). 2014;16:814–21.

95.

Jamil LH, Chindris AM, Gill KR, et al. Glycemic control after total pancreatectomy for intraductal papillary mucinous neoplasm: an exploratory study. HPB Surg. 2012;2012:381328.PubMedCentralPubMed

96.

Crippa S, Tamburrino D, Partelli S, et al. Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery. 2011;149:79–86.PubMed

97.

Larsen S, Hilsted J, Philipsen EK, et al. A comparative study of microvascular complications in patients with secondary and type 1 diabetes. Diabet Med. 1990;7:815–8.PubMed

98.

Levitt NS, Adams G, Salmon J, et al. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM. Diabetes Care. 1995;18:971–4.PubMed

99.

Gasiorowska A, Czupryniak L, Malecka-Panas E, et al. [Microvascular complications in pancreatic diabetes]. Pol Arch Med Wewn. 2001;105:469–74.PubMed

100.

Briani G, Riva F, Midena E, et al. Prevalence of microangiopathic complications in hyperglycemia secondary to pancreatic disease. J Diabet Complicat. 1988;2:50–2.

101.••

Tiengo A, Segato T, Briani G, et al. The presence of retinopathy in patients with secondary diabetes following pancreatectomy or chronic pancreatitis. Diabetes Care. 1983;6:570–4. Demonstration that microvascular complications are present also in diabetes after pancreatic resection.PubMed

102.

Couet C, Genton P, Pointel JP, et al. The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus. Diabetes Care. 1985;8:323–8.PubMed

103.

Marre M, Hallab M, Roy J, et al. Glomerular hyperfiltration in type I, type II, and secondary diabetes. J Diabetes Complicat. 1992;6:19–24.PubMed

104.

Mohan V, Ramachandran A, Viswanathan M. Two case reports of macrovascular complications in fibrocalculous pancreatic diabetes. Acta Diabetol Lat. 1989;26:345–9.PubMed

105.

Wakasugi H, Hara Y, Abe M, Katsuda Y. Angiopathies in pancreatic diabetes resulting from chronic pancreatitis. Int J Pancreatol. 1998;23:175–80.PubMed

106.

Ziegler O, Candiloros H, Guerci B, et al. Lower-extremity arterial disease in diabetes mellitus due to chronic pancreatitis. Diabete Metab. 1994;20:540–5.PubMed

107.

Wakasugi H, Funakoshi A, Iguchi H. Clinical assessment of pancreatic diabetes caused by chronic pancreatitis. J Gastroenterol. 1998;33:254–9.PubMed

108.

Ata A, Lee J, Bestle SL, et al. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145:858–64.PubMed

109.

Meynaar IA, Eslami S, Abu-Hanna A, et al. Blood glucose amplitude variability as predictor for mortality in surgical and medical intensive care unit patients: a multicenter cohort study. J Crit Care. 2012;27:119–24.PubMed

110.

Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38:838–42.PubMed

111.

Dossett LA, Cao H, Mowery NT, et al. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg. 2008;74:679–85. discussion 685.PubMed

112.••

van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67. Demonstration that intensive insulin therapy in critically ill patients increases survival.PubMed

113.

Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821–7.PubMedCentralPubMed

114.••

Eshuis WJ, Hermanides J, van Dalen JW, et al. Early postoperative hyperglycemia is associated with postoperative complications after pancreatoduodenectomy. Ann Surg. 2011;253:739–44. Demonstration that hyperglycemia is associated with postoperative complications after pancreatoduodenectomy.PubMed

115.

Hanazaki K. Tight glycemic control using an artificial endocrine pancreas may play an important role in preventing infection after pancreatic resection. World J Gastroenterol. 2012;18:3787–9.PubMedCentralPubMed

116.

Duncan AE. Hyperglycemia and perioperative glucose management. Curr Pharm Des. 2012;18:6195–203.PubMedCentralPubMed

117.

Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.PubMed

118.

Okabayashi T, Shima Y, Sumiyoshi T, et al. Intensive versus intermediate glucose control in surgical intensive care unit patients. Diabetes Care. 2014;37:1516–24.PubMed

119.••

Hanazaki K, Kitagawa H, Yatabe T, et al. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia. Am J Surg. 2014;207:935–41. Demonstration that intensive insulin therapy reduce perisurgical complications.PubMed

120.

Choudhary P, Ramasamy S, Green L, et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care. 2013;36:4160–2.PubMedCentralPubMed

121.

Tran TC, van Lanschot JJ, Bruno MJ, van Eijck CH. Functional changes after pancreatoduodenectomy: diagnosis and treatment. Pancreatology. 2009;9:729–37.PubMed

122.

Hamilton L, Jeyarajah DR. Hemoglobin A1c can be helpful in predicting progression to diabetes after Whipple procedure. HPB (Oxford). 2007;9:26–8.

123.

Riediger H, Adam U, Fischer E, et al. Long-term outcome after resection for chronic pancreatitis in 224 patients. J Gastrointest Surg. 2007;11:949–59. discussion 959–60.PubMed

124.

Najarian JS, Sutherland DE, Matas AJ, Goetz FC. Human islet autotransplantation following pancreatectomy. Transplant Proc. 1979;11:336–40.PubMed

125.

Bramis K, Gordon-Weeks AN, Friend PJ, et al. Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Br J Surg. 2012;99:761–6.PubMed

126.

Bellin MD, Beilman GJ, Dunn TB, et al. Islet autotransplantation to preserve beta cell mass in selected patients with chronic pancreatitis and diabetes mellitus undergoing total pancreatectomy. Pancreas. 2013;42:317–21.PubMedCentralPubMed

127.••

Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg. 2012;214:409–24. discussion 424–6. The largest cohort of patients undergoing islet autotransplantation for chronic pancreatitis.PubMedCentralPubMed

128.

Bellin MD, Freeman ML, Schwarzenberg SJ, et al. Quality of life improves for pediatric patients after total pancreatectomy and islet autotransplant for chronic pancreatitis. Clin Gastroenterol Hepatol. 2011;9:793–9.PubMedCentralPubMed

129.

Bellin MD, Carlson AM, Kobayashi T, et al. Outcome after pancreatectomy and islet autotransplantation in a pediatric population. J Pediatr Gastroenterol Nutr. 2008;47:37–44.PubMed

130.

Webb MA, Illouz SC, Pollard CA, et al. Islet auto transplantation following total pancreatectomy: a long-term assessment of graft function. Pancreas. 2008;37:282–7.PubMed

131.

Wilson GC, Sutton JM, Salehi M, et al. Surgical outcomes after total pancreatectomy and islet cell autotransplantation in pediatric patients. Surgery. 2013;154:777–83. discussion 783–4.PubMed

132.

Sutton JM, Schmulewitz N, Sussman JJ, et al. Total pancreatectomy and islet cell autotransplantation as a means of treating patients with genetically linked pancreatitis. Surgery. 2010;148:676–85. discussion 685–6.PubMed

133.

Clayton HA, Davies JE, Pollard CA, et al. Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the Leicester General Hospital. Transplantation. 2003;76:92–8.PubMed

134.

White SA, Davies JE, Pollard C, et al. Pancreas resection and islet autotransplantation for end-stage chronic pancreatitis. Ann Surg. 2001;233:423–31.PubMedCentralPubMed

135.

Johnson PR, White SA, Robertson GS, et al. Pancreatic islet autotransplantation combined with total pancreatectomy for the treatment of chronic pancreatitis—the Leicester experience. J Mol Med (Berl). 1999;77:130–2.

136.

Garcea G, Weaver J, Phillips J, et al. Total pancreatectomy with and without islet cell transplantation for chronic pancreatitis: a series of 85 consecutive patients. Pancreas. 2009;38:1–7.PubMed

137.

Morgan KA, Nishimura M, Uflacker R, Adams DB. Percutaneous transhepatic islet cell autotransplantation after pancreatectomy for chronic pancreatitis: a novel approach. HPB (Oxford). 2011;13:511–6.

138.

Ahmad SA, Lowy AM, Wray CJ, et al. Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg. 2005;201:680–7.PubMed

139.

Sutherland DE, Gruessner AC, Carlson AM, et al. Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation. 2008;86:1799–802.PubMed

140.

Dudeja V, Beilman GJ, Vickers SM. Total pancreatectomy with islet autotransplantation in patients with malignancy: are we there yet? Ann Surg. 2013;258:219–20.PubMed

141.••

Balzano G, Maffi P, Nano R, et al. Extending indications for islet autotransplantation in pancreatic surgery. Ann Surg. 2013;258:210–8. The largest cohort of patients undergoing islet autotransplantation for pancreatic disease other than chronic pancreatitis.PubMed

Titel: Diabetes After Pancreatic Surgery: Novel Issues
verfasst von: Marina Scavini
Erica Dugnani
Valentina Pasquale
Daniela Liberati
Francesca Aleotti
Gaetano Di Terlizzi
Giovanna Petrella
Gianpaolo Balzano
Lorenzo Piemonti
Publikationsdatum: 01.04.2015
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 4/2015
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-015-0589-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Vascular Complications in the Diabetic Pregnancy

Bariatric Surgery: Prevalence, Predictors, and Mechanisms of Diabetes Remission

Management of the Hospitalized Transplant Patient

The Impact of Health Systems on Diabetes Care in Low and Lower Middle Income Countries

Diabetes and Epilepsy in Children and Adolescents